Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
Diabetes, Obesity & Metabolism
|
June 10, 2017
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions
Ronan Roussel, Philippe Gabriel Steg, Kamel Mohammedi, et al.
Diabetes, Obesity & Metabolism
|
March 4, 2023
Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study
Kamel Mohammedi, Narimene Belhatem, Tina Landsvig Berentzen, et al.
Biological Chemistry
|
January 18, 2013
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency
Louis Potier, Ludovic Waeckel, Christine Richer, et al.
Current Pharmaceutical Design
|
July 7, 2011
Kinins as therapeutic agents in cardiovascular and renal diseases
Francois Alhenc-Gelas, Nadine Bouby, Christine Richer, et al.
Diabetes Care
|
January 25, 2020
Chronic Kidney Disease, Diabetes, and Risk of Mortality After Acute Myocardial Infarction: Insight From the FAST-MI Program
Louis Potier, Ronan Roussel, Marianne Zeller, et al.
Journal of the American College of Cardiology
|
February 23, 2010
Cryoglobulin-induced cardiomyopathy
Alexandre Karras, Louis Potier, Anne-Hélène Reboux, et al.
Biological Chemistry
|
September 14, 2016
Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
Dorinne Desposito, Ludovic Waeckel, Louis Potier, et al.
Advances in Therapy
|
December 5, 2024
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis
Gottfried Rudofsky, Markus Menzen, Louis Potier, et al.
Cardiovascular Diabetology
|
January 9, 2016
Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
Kamel Mohammedi, Louis Potier, Narimène Belhatem, et al.
Endocrinology
|
June 7, 2012
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse
Ludovic Waeckel, Louis Potier, Catherine Chollet, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
Diabetes, Obesity & Metabolism
|
June 10, 2017
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions
Ronan Roussel, Philippe Gabriel Steg, Kamel Mohammedi, et al.
Diabetes, Obesity & Metabolism
|
March 4, 2023
Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study
Kamel Mohammedi, Narimene Belhatem, Tina Landsvig Berentzen, et al.
Biological Chemistry
|
January 18, 2013
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency
Louis Potier, Ludovic Waeckel, Christine Richer, et al.
Current Pharmaceutical Design
|
July 7, 2011
Kinins as therapeutic agents in cardiovascular and renal diseases
Francois Alhenc-Gelas, Nadine Bouby, Christine Richer, et al.
Diabetes Care
|
January 25, 2020
Chronic Kidney Disease, Diabetes, and Risk of Mortality After Acute Myocardial Infarction: Insight From the FAST-MI Program
Louis Potier, Ronan Roussel, Marianne Zeller, et al.
Journal of the American College of Cardiology
|
February 23, 2010
Cryoglobulin-induced cardiomyopathy
Alexandre Karras, Louis Potier, Anne-Hélène Reboux, et al.
Biological Chemistry
|
September 14, 2016
Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
Dorinne Desposito, Ludovic Waeckel, Louis Potier, et al.
Advances in Therapy
|
December 5, 2024
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis
Gottfried Rudofsky, Markus Menzen, Louis Potier, et al.
Cardiovascular Diabetology
|
January 9, 2016
Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
Kamel Mohammedi, Louis Potier, Narimène Belhatem, et al.
Endocrinology
|
June 7, 2012
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse
Ludovic Waeckel, Louis Potier, Catherine Chollet, et al.
Page
of 10